Company intelligence / Profile preview

Oncology Drug Development Consulting

Nashville, Tennessee, United Statesailseoncology.com ↗

Ownership: Private
Employees: ~31
Development stage: Other

Overview

Medelis provides strategic consulting and full-service CRO capabilities for oncology drug development. They assist with adaptive trial design, regulatory strategy, protocol writing, bioequivalence studies in cancer patients, and clinical operations management. Their expertise spans preclinical to Phase 3 trials with an emphasis on efficient study design and regulatory navigation to accelerate time-to-market for new cancer therapies.

Therapeutic areas: Oncology
Modalities: Small moleculeMonoclonal antibodyImmunotherapy
Industry: Consulting

Partnerships

Notable partnerships include collaborations with biopharma sponsors seeking oncology trial acceleration; specifics are confidential/client-based.

Beyond the preview

Go deeper on Oncology Drug Development Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oncology Drug Development Consulting.

Explore the full profile